131 results
Page 5 of 7
8-K
EX-4.3
tqsdt3tu 0q
13 Jan 11
Provectus Pharmaceuticals, Inc. Announces Registered Direct Offering of Common Stock and Warrants In Aggregate Amount of $5.1 Million
12:00am
8-K
EX-4.1
5le9ec
13 Jan 11
Provectus Pharmaceuticals, Inc. Announces Registered Direct Offering of Common Stock and Warrants In Aggregate Amount of $5.1 Million
12:00am
8-K
EX-10.1
5n8vr5kna9rj6obd
13 Jan 11
Provectus Pharmaceuticals, Inc. Announces Registered Direct Offering of Common Stock and Warrants In Aggregate Amount of $5.1 Million
12:00am
424B5
o69v5rsd7 3ul
13 Jan 11
Prospectus supplement for primary offering
12:00am
8-K
EX-4.2
ekz2xl2i99l la40w
13 Jan 11
Provectus Pharmaceuticals, Inc. Announces Registered Direct Offering of Common Stock and Warrants In Aggregate Amount of $5.1 Million
12:00am
424B5
py101u 4pk
23 Dec 10
Prospectus supplement for primary offering
12:00am
8-K
EX-4.1
kpdcel
23 Dec 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
ynuzy4nn36 k1q
23 Dec 10
Entry into a Material Definitive Agreement
12:00am
POS AM
8b6r6
27 Jul 10
Prospectus update (post-effective amendment)
12:00am
424B3
sigxq
5 Apr 10
Prospectus supplement
12:00am
8-K
EX-10.1
j0m7uvmhhl
12 Mar 10
Provectus Pharmaceuticals Executes Purchase Agreements
12:00am
8-K
EX-3.1
1dl93jes
12 Mar 10
Provectus Pharmaceuticals Executes Purchase Agreements
12:00am
8-K
EX-10.2
levfnaymf9
12 Mar 10
Provectus Pharmaceuticals Executes Purchase Agreements
12:00am
CORRESP
9who1wz
22 Sep 09
Correspondence with SEC
12:00am